Clinical Trial Update: Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa [Phase 2]

View source ↗

Summary

A Phase 2 trial in breast cancer comparing cisplatin to the doxorubicin/cyclophosphamide regimen has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-03